COMPANY OVERVIEW

Glythera is an emerging biotechnology company focused on developing antibody-based therapies for the treatment of cancer as well as broader based therapeutics.

---

LOCATION

Newcastle-upon-Tyne, , UK

---

THERAPEUTIC AREAS

Oncology

---

WEBSITE

https://www.glythera.com/

---

CAREER WEBSITE

https://www.glythera.com/careers/our-people

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Sep 10, 2018

Glythera Announces Corporate Name Change and Rebranding to Iksuda Therapeutics

Apr 30, 2018

Glythera Appoints Professor Kerry Chester to SAB

Jan 17, 2018

Glythera Appoints Chief Scientific Officer and Strengthens SAB

Sep 26, 2017

Glythera Licenses Novel Payload Class from Cancer Research UK for the Development of Next-Generation Antibody Drug Conjugates

Sep 20, 2017

Glythera and IONTAS Enter into License Agreement for the Development of Multiple Antibodies for Next-Generation Antibody Drug Conjugates

For More Press Releases

---